STAT

Lapses by EpiPen manufacturer tied to ‘serious’ problems, patient deaths, FDA says

A Pfizer unit that makes the EpiPen device for Mylan experienced a quality-control meltdown that included a failure to investigate “serious” problems associated with an unspecified number of patient deaths.

Throughout last year, Meridian Medical Technologies received hundreds of complaints that the EpiPen device, which is used to combat serious allergic reactions, failed to operate during life-threatening emergencies. Yet the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Drug For Lung Cancer, A Novo Plant Fire, And More
The FDA approved an innovative treatment from Amgen for patients with small cell lung cancer who have exhausted all other options.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Takeda Restructuring, Pfizer Settling Zantac Suits, And More
Pfizer agreed to settle more than 10,000 cases accusing it of hiding cancer risks of its Zantac heartburn drug.

Related Books & Audiobooks